Real-time enrollment status for this gadolinium exposure effects clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT04373564 |
| Recruiting Status | Recruiting |
| Condition | Gadolinium Exposure Effects |
| Phase | Clinical Trial |
| Target Enrollment | 2,076 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Guerbet |
| Last Updated on CT.gov | January 22, 2026 (Jan 22, 2026) |
As of March 2, 2026: Clinical trial NCT04373564 is currently recruiting participants. This clinical trial study for gadolinium exposure effects is actively seeking new participants at 16 locations across the United States. The study is sponsored by Guerbet. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04373564 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04373564 was last updated Jan 22, 2026 (January 22, 2026). HelloStudys verifies this status automatically.